Delivery Order SPE2DB22D2206-SPE2DB24FHY70
Award Date
6/27/24
Potential Completion Date
7/19/24
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the prescription drug NUBEQA 300 MG TABLET 120S to federal government agencies. The contract, valued at $4,683.97, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of December 10, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $7,280.00 firm fixed price delivery order is for the supply of 120 tablets of the drug NUBEQA 300 MG. The contract has an ultimate completion date of June 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $7,641.98. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a medical product, and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
This federal contract award, valued at $10,555.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NUBEQA 300 MG TABLET 120S. The contract is a Firm Fixed Price Delivery Order with a completion date of July 25, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a completion date of June 27, 2025. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,641.98 for the supply of NUBEQA 300 MG TABLET 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 31, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a wide range of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical program. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to deliver medications, specialty drugs, and critical care materials to DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products, including the prescription drug NUBEQA 300 MG TABLET 120S, to the Defense Logistics Agency (DLA). The $3,518.40 firm fixed-price delivery order has a completion date of July 11, 2024 and is not designated as a set-aside contract. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract...